US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
EP0420937B1
(en)
|
1988-06-21 |
1994-11-09 |
Genentech, Inc. |
Therapeutic compositions for the treatment of myocardial infarction
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
KR100272077B1
(ko)
|
1990-08-29 |
2000-11-15 |
젠팜인터내셔날,인코포레이티드 |
이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
ATE207080T1
(de)
|
1991-11-25 |
2001-11-15 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
JPH0656382A
(ja)
|
1992-08-04 |
1994-03-01 |
Kawasaki Steel Corp |
コークス乾式消火装置のバケット巻上機の吊ビーム装置
|
MA24512A1
(fr)
*
|
1996-01-17 |
1998-12-31 |
Univ Vermont And State Agrienl |
Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
|
GB9818110D0
(en)
|
1998-08-19 |
1998-10-14 |
Weston Medical Ltd |
Needleless injectors and other devices
|
US6096002A
(en)
|
1998-11-18 |
2000-08-01 |
Bioject, Inc. |
NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
|
CN1214043C
(zh)
|
1998-12-01 |
2005-08-10 |
蛋白质设计实验室股份有限公司 |
抗γ-干扰素的人化抗体
|
JP5198704B2
(ja)
|
2000-03-03 |
2013-05-15 |
メディミューン リミティド |
エオタキシンに対するヒト抗体及びそれらの使用
|
MXPA06000583A
(es)
|
2003-07-15 |
2006-03-30 |
Amgen Inc |
Anticuerpos neutralizantes anti-ngf humano como inhibidores selectivos de la via del ngf.
|
US7208601B2
(en)
*
|
2003-08-08 |
2007-04-24 |
Mjalli Adnan M M |
Aryl and heteroaryl compounds, compositions, and methods of use
|
KR101017301B1
(ko)
*
|
2004-12-21 |
2011-02-28 |
메드임뮨 리미티드 |
앤지오포이에틴-2에 대한 항체 및 그의 용도
|
NZ583153A
(en)
|
2004-12-21 |
2011-06-30 |
Centocor Ortho Biotech Inc |
Anti-IL-12 antibodies, epitopes, compositions, methods and uses
|
US8318906B2
(en)
|
2005-04-15 |
2012-11-27 |
The Regents Of The University Of California |
EMP2 antibodies and their therapeutic uses
|
EP1896582A4
(en)
|
2005-05-09 |
2009-04-08 |
Ono Pharmaceutical Co |
HUMAN MONOCLONAL ANTIBODIES FOR PROGRAMMED DEATH 1 (MP-1) AND METHODS FOR TREATING CANCER USING ANTI-MP-1 ANTIBODIES ALONE OR ASSOCIATED WITH OTHER IMMUNOTHERAPIES
|
CA2612241C
(en)
|
2005-07-01 |
2018-11-06 |
Medarex, Inc. |
Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
|
EP1957539B1
(en)
|
2005-12-08 |
2013-04-17 |
Medarex, Inc. |
Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and their use
|
JP5512128B2
(ja)
|
2005-12-08 |
2014-06-04 |
メダレックス・リミテッド・ライアビリティ・カンパニー |
フコシルgm1に対するヒトモノクローナル抗体および抗フコシルgm1を使用するための方法
|
KR20220031126A
(ko)
|
2006-06-06 |
2022-03-11 |
얀센 백신스 앤드 프리벤션 비.브이. |
장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
US7833527B2
(en)
|
2006-10-02 |
2010-11-16 |
Amgen Inc. |
Methods of treating psoriasis using IL-17 Receptor A antibodies
|
CA2680741A1
(en)
|
2007-03-22 |
2009-01-15 |
The Regents Of The University Of California |
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
|
GB0708585D0
(en)
|
2007-05-03 |
2007-06-13 |
Queen Mary & Westfield College |
Novel antibody and use in diagnosis and therapy of arthropathies
|
US7982016B2
(en)
|
2007-09-10 |
2011-07-19 |
Amgen Inc. |
Antigen binding proteins capable of binding thymic stromal lymphopoietin
|
AU2008298603B2
(en)
|
2007-09-14 |
2015-04-30 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
AR068566A1
(es)
|
2007-09-26 |
2009-11-18 |
Amgen Inc |
Proteinas fijadoras de antigeno de factor de crecimiento del tipo factor de crecimiento epidermico fijador de heparina
|
LT3002298T
(lt)
|
2007-11-21 |
2019-12-10 |
Univ Oregon Health & Science |
Monokloniniai antikūnai prieš faktorių xi ir jų panaudojimo būdai
|
US8188235B2
(en)
*
|
2008-06-18 |
2012-05-29 |
Pfizer Inc. |
Antibodies to IL-6 and their uses
|
US20110159006A1
(en)
|
2008-06-19 |
2011-06-30 |
Erik Hack |
Use of anti-factor xi antibodies for prevention of thrombus formation
|
US9000131B2
(en)
|
2008-07-31 |
2015-04-07 |
The Regents Of The University Of California |
Antibodies that neutralize botulinum neurotoxins
|
ES2618567T3
(es)
|
2008-10-31 |
2017-06-21 |
Janssen Biotech, Inc. |
Antagonistas de receptor de tipo Toll 3
|
US9212223B2
(en)
|
2008-11-25 |
2015-12-15 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
US9452227B2
(en)
|
2008-11-25 |
2016-09-27 |
Alderbio Holdings Llc |
Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
|
HUE042940T2
(hu)
|
2008-12-18 |
2019-07-29 |
Univ Oregon Health & Science |
Anti-FXI antitestek és alkalmazási eljárások
|
CA3018235C
(en)
|
2009-03-20 |
2021-01-12 |
Amgen Inc. |
Carrier immunoglobulins and uses thereof
|
AU2010236256C1
(en)
|
2009-04-16 |
2015-10-22 |
Abbvie Biotherapeutics Inc. |
Anti-TNF-alpha antibodies and their uses
|
WO2010126066A1
(ja)
|
2009-04-27 |
2010-11-04 |
協和発酵キリン株式会社 |
血液腫瘍治療を目的とした抗IL-3Rα抗体
|
AU2010308030B2
(en)
|
2009-10-12 |
2014-05-29 |
Pfizer Inc. |
Cancer treatment
|
US9045536B2
(en)
|
2009-12-23 |
2015-06-02 |
Merck Sharp & Dohme Corp. |
Cell line 3M
|
EP3336225B1
(en)
|
2010-07-16 |
2020-02-19 |
Adimab, LLC |
Antibody libraries
|
KR101919170B1
(ko)
|
2010-11-19 |
2018-11-15 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
중화 항-ccl20 항체
|
CN102559720B
(zh)
*
|
2010-12-16 |
2015-05-13 |
中国科学院福建物质结构研究所 |
人源凝血因子xi催化结构域的表达、纯化及结晶
|
IL310186A
(en)
|
2011-01-06 |
2024-03-01 |
Takeda Pharmaceuticals Co |
KALLIKREIN PLASMA BINDING PROTEINS
|
JP6082997B2
(ja)
|
2011-04-01 |
2017-02-22 |
メモリアル スローン−ケタリング キャンサー センター |
Hla−a2により提示されるwt1ペプチドへのt細胞受容体様抗体
|
DK3424953T3
(en)
|
2011-06-06 |
2020-11-02 |
Novo Nordisk As |
Terapeutiske antistoffer
|
IL230564B2
(en)
*
|
2011-07-22 |
2023-09-01 |
Csl Ltd |
Anticoagulant monoclonal antibodies anti–factor xii/fxiia, a method for their preparation, a pharmaceutical compound containing them and medical uses.
|
US8765385B2
(en)
|
2011-10-27 |
2014-07-01 |
Ravindra Kumar |
Method of detection of neutralizing anti-actriib antibodies
|
EP2623110A1
(en)
|
2012-01-31 |
2013-08-07 |
CSL Behring GmbH |
Factor XII inhibitors for the treatment of neurological inflammatory disorders
|
PL2650310T3
(pl)
|
2012-04-13 |
2017-01-31 |
Rottapharm Biotech S.R.L. |
Przeciwciało przeciw-ADAMTS-5, jego pochodne i zastosowania
|
AU2013258043B2
(en)
|
2012-05-10 |
2017-11-30 |
Bayer Pharma Aktiengesellschaft |
Antibodies capable of binding to the coagulation factor XI and/or its activated form factor XIa and uses thereof
|
US9944707B2
(en)
|
2012-05-17 |
2018-04-17 |
Sorrento Therapeutics, Inc. |
Antibodies that bind epidermal growth factor receptor (EGFR)
|
US20140004121A1
(en)
|
2012-06-27 |
2014-01-02 |
Amgen Inc. |
Anti-mesothelin binding proteins
|
US9498532B2
(en)
|
2013-03-13 |
2016-11-22 |
Novartis Ag |
Antibody drug conjugates
|
JPWO2015141826A1
(ja)
|
2014-03-20 |
2017-04-13 |
国立感染症研究所長 |
C型肝炎ウイルスに対する感染阻害活性を有する抗体
|
CN106456763B
(zh)
|
2014-06-03 |
2018-03-13 |
埃克斯生物科技公司 |
用于治疗和预防金黄色葡萄球菌感染的组合物和方法
|
JP6669749B2
(ja)
|
2014-08-08 |
2020-03-18 |
アレクトル エルエルシー |
抗trem2抗体及びその使用方法
|
US9139653B1
(en)
|
2015-04-30 |
2015-09-22 |
Kymab Limited |
Anti-human OX40L antibodies and methods of treatment
|
RS62546B1
(sr)
|
2015-04-07 |
2021-12-31 |
Alector Llc |
Antitela protiv sortilina i postupci za njihovu upotrebu
|
WO2016201389A2
(en)
|
2015-06-12 |
2016-12-15 |
Alector Llc |
Anti-cd33 antibodies and methods of use thereof
|
JOP20200312A1
(ar)
|
2015-06-26 |
2017-06-16 |
Novartis Ag |
الأجسام المضادة للعامل xi وطرق الاستخدام
|
WO2017015619A1
(en)
|
2015-07-23 |
2017-01-26 |
The Regents Of The University Of California |
Antibodies to coagulation factor xia and uses thereof
|
US10358497B2
(en)
|
2015-09-29 |
2019-07-23 |
Amgen Inc. |
Methods of treating cardiovascular disease with an ASGR inhibitor
|